A new Nature Medicine Perspective, “Immune Aging Biomarkers for Clinical Trials,” tackles a question at the heart of HIP’s mission: there’s still no agreed-upon way to measure immune aging. Co-authored by HIP Co-Chief Scientific Officers Shai Shen-Orr and John Tsang, alongside researchers from Stanford, Yale, UConn, University College London, the National Institute on Aging, and others, the…

Read More